You are here:Home-Chemical Inhibitors & Agonists-Apoptosis-Bcl-2-Venetoclax
Venetoclax

Chemical Structure : Venetoclax

CAS No.: 1257044-40-8

Venetoclax (ABT-199, GDC-0199, ABT199)

Catalog No.: PC-49764Not For Human Use, Lab Use Only.

Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with Ki value of <0.01 nM.

Packing Price Stock Quantity
50 mg $98 In stock
100 mg $138 In stock
500 mg $278 In stock
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Venetoclax (ABT-199, GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with Ki value of <0.01 nM.
Venetoclax (ABT-199) displays >4800-fold selectivity for Bcl-2 over Bcl-xL and Bcl-w, and displays no measurable activity at Mcl-1.
Venetoclax (ABT-199) potently induces apoptosis in FL5.12-BCL-2 cells (EC50=261 nM) and reduces tumor burden in chronic lymphocytic leukemia (CLL) primary samples (EC50 =3 nM).
Venetoclax (ABT-199 enhances efficacy of clinically relevant chemotherapy and immunotherapy drugs.
Venetoclax (ABT-199) exhibits binding to SARS-CoV-2 3C-like protease (3CLpro) active site in a virtual screen.
Venetoclax (ABT-199) reverses oxidative phosphorylation in acute myeloid leukemia cells (AML), in vitro and in vivo.

Physicochemical Properties

M.Wt 868.45
Formula C45H50ClN7O7S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfonyl)benzamide

References

1. Souers AJ, et al. Nat Med. 2013 Feb;19(2):202-8.

2. Vogler M, et al. Br J Haematol. 2013 Oct;163(1):139-42.

3. Vandenberg CJ, et al. Blood. 2013 Mar 21;121(12):2285-8.

4. Vaillant F, et al. Cancer Cell. 2013 Jul 8;24(1):120-9.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: